A new study by Mayo Clinic Comprehensive Cancer Center researchers found that the presence of a specific genetic ...
Q4 2024 Earnings Call Transcript March 17, 2025 FibroGen, Inc. reports earnings inline with expectations. Reported EPS is $-0 ...
Telix’s Illuccix prostate cancer PSMA-PET imaging agent approved in the Netherlands: Melbourne, Australia Wednesday, March 19, 2025, 12:00 Hrs [IST] Telix, a biopharmaceutical c ...
Zydus Lifesciences received final USFDA approval to manufacture Apalutamide tablets for prostate cancer, following last ...
Zydus Lifesciences said that it has received final approval from the United States Food and Drug Administration (US FDA) to manufacture Apalutamide tablets, 60 mg.
MedPage Today on MSN20h
End of the Road for Immune Checkpoint Inhibitors in Prostate Cancer?Adding an immune checkpoint inhibitor (ICI) to chemotherapy for advanced prostate cancer failed to improve survival as ...
Zydus Lifesciences shares rose 8.34 per cent on March 19, touching an intraday high of Rs 910.30 at 1:00 PM when the company ...
Erzsébet Merényi, a statistics research professor at Rice University, and co-investigators at The University of Texas MD Anderson Cancer Center Pratip Bhattacharya, professor of cancer systems imaging ...
A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment outcomes for men with prostate cancer by helping physicians determine who is most ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback